Skip to content
ParamountParamount Inc. Tokyo, Japan
Dry Susp.

Lococin

250 mg

Lincomycin

Segment 05 · Tetracyclines, Lincosamides & Other Classes

Lococin250 mg

Dry Suspension

Lincomycin

Dry Susp.

Lococin

250 mg

Lincomycin

Lincosamide antibiotic for serious streptococcal and staphylococcal infections.

Export fast-track. DRAP export registration in about a month for products developed against export orders. Describe the formulation

Generic composition
Lincomycin
Strength
250 mg
Dosage form
Dry Suspension
Pack sizes
60 ml

Other forms & strengths of Lococin

Manufacturer
Paramount Pharmaceuticals, Islamabad
Licence
DML 000439 · DRAP GMP
Release
Batch-tested, with Certificate of Analysis

For healthcare professionals. Registration status, brand names and pack presentations vary by market. Experienced a side effect? Report it here.

Lococin

How it's made

Dry suspensions are made as a dry powder blend, filled into bottles; water is added only when the medicine is dispensed. Made in the general production section.

How all our dosage forms are made →
  1. 01

    Dispensing

    Each raw material is released by QC, then weighed for the batch under a second person's check.

  2. 02

    Dry blending

    The active ingredient is blended with sweeteners, flavour and suspending agents as a dry powder.

  3. 03

    Powder filling

    Bottles are filled to a set powder weight; water is added only by the pharmacist or patient.

  4. 04

    Capping and labelling

    Bottles are sealed and labelled with the batch number and expiry date.

Batch release tests

  • Fill weight
  • Assay of the active ingredient
  • Reconstitution and pH
  • Water content
  • Microbial limits

Limits for this product are on each batch's Certificate of Analysis.